Family history and polygenic risk of cardiovascular disease: Independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy. (August 2020)

• Record Type: Journal Article
• Authors: Timmerman, Nathalie; de Kleijn, Dominique P.V.; de Borst, Gert J.; den Ruijter, Hester M.; Asselbergs, Folkert W.; Pasterkamp, Gerard; Haitjema, Saskia; van der Laan, Sander W.
• Is Part Of: Atherosclerosis. Volume 307(2020)
• Page Start: 121
• Page End: 129
• Publication Date: 2020-08
• Subjects: Atherosclerosis -- Polygenic risk score -- Family history -- Vascular biology -- Carotid artery stenosis -- Carotid endarterectomy; Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2020.04.013
• Languages: English
• ISSNs: 0021-9150

Abstract

Abstract: Background and aims: Family history (FHx) of cardiovascular disease (CVD) is a risk factor for CVD and a proxy for cardiovascular heritability. Polygenic risk scores (PRS) summarizing >1 million variants for coronary artery disease (CAD) are associated with incident and recurrent CAD events. However, little is known about the influence of FHx or PRS on secondary cardiovascular events (sCVE) in patients undergoing carotid endarterectomy (CEA). Methods: We included 1788 CEA patients from the Athero-Express Biobank. A weighted PRS for CAD including 1.7 million variants was calculated (MetaGRS). The composite endpoint of sCVE during three years of follow-up included coronary, cerebrovascular and peripheral events and cardiovascular death. We assessed the impact of FHx and MetaGRS on sCVE and carotid plaque composition. Results: Positive FHx was associated with a higher 3-year risk of sCVE independent of cardiovascular risk factors and MetaGRS (adjusted HR 1.40, 95%CI 1.07–1.82, p = 0.013). Patients in the highest MetaGRS quintile had a higher 3-year risk of sCVE compared to the rest of the cohort independent of cardiovascular risk factors including FHx (adjusted HR 1.35, 95%CI 1.01–1.79, p = 0.043), and their atherosclerotic plaques contained more fat (adjusted OR 1.59, 95%CI, 1.11–2.29, p = 0.013) and more macrophages (OR 1.49, 95%CI 1.12–1.99, p = 0.006). Conclusions: In CEA patients, both positive FHx and higher MetaGRS were independently associated with increased risk of sCVE. Moreover, higher MetaGRS was associated with vulnerable plaque characteristics. Future studies should unravel underlying mechanisms and focus on the added value of PRS and FHx in individual risk prediction for sCVE. Graphical abstract: Image 1 Highlights: Positive family history (FHx) is independently associated with higher 3-year risk of secondary cardiovascular events (sCVE). Higher genetic risk (MetaGRS) is associated with higher 3-year risk of sCVE, independent of FHx and risk factors. Higher MetaGRS was associated with more vulnerable plaque characteristics suggesting putative underlying mechanisms. Future studies should further unravel exact underlying pathophysiological mechanisms. Future studies should explore the value of MetaGRS and FHx in individual risk prediction for sCVE.